Compounds > dofequidar
Page last updated: 2024-09-05

dofequidar and etoposide

dofequidar has been researched along with etoposide in 3 studies

Compound Research Comparison

Studies
(dofequidar)		Trials
(dofequidar)		Recent Studies (post-2010)
(dofequidar)		Studies
(etoposide)		Trials
(etoposide)		Recent Studies (post-2010) (etoposide)
402518,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomydofequidar (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ford, PJ; Germann, UA; Harding, MW; Mason, VS; Shlyakhter, D1
Aizawa, K; Fukuda, M; Ikeda, K; Kimura, Y; Kohno, S; Mizuta, Y; Nakamura, T; Noguchi, Y; Oka, M; Soda, H; Terashi, K; Tsuruo, T1
Hanibuchi, M; Higasida, T; Nishioka, Y; Nokihara, H; Sone, S; Tsuruo, T; Yano, S1

Other Studies

3 other study(ies) available for dofequidar and etoposide

ArticleYear
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
    Anti-cancer drugs, 1997, Volume: 8, Issue:2

    Topics: Acridines; Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; HL-60 Cells; Humans; Isoquinolines; Multidrug Resistance-Associated Proteins; Piperidines; Pyridines; Quinolines; Tetrahydroisoquinolines; Tritium; Verapamil; Vincristine

1997
Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.
    Biochemical and biophysical research communications, 1999, Feb-24, Volume: 255, Issue:3

    Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Leukotriene C4; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; Quinolines; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine

1999
A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
    Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Neoplasm Metastasis; Quinolines; Vincristine; Xenograft Model Antitumor Assays

2001